Skip to main content

. 1977 Jul 30;2(6082):297–298. doi: 10.1136/bmj.2.6082.297

Interstitial pulmonary fibrosis: a new side effect of practolol.

T M Erwteman, M C Braat, W G van Aken

PMCID: PMC1630827 PMID: 871866

297

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Brown P., Baddeley H., Read A. E., Davies J. D., McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet. 1974 Dec 21;2(7895):1477–1481. doi: 10.1016/s0140-6736(74)90218-9. [DOI] [PubMed] [Google Scholar]
Fraser D. M., Irvine N. A. Letter: Joint effusions and practolol. Lancet. 1976 Jan 10;1(7950):89–89. doi: 10.1016/s0140-6736(76)90181-1. [DOI] [PubMed] [Google Scholar]
Kristensen K., Kristensen J. S., Thorborg J. V. Letter: Fractolol and sclerosing peritonitis. Lancet. 1975 Mar 29;1(7909):741–742. doi: 10.1016/s0140-6736(75)91646-3. [DOI] [PubMed] [Google Scholar]
MacKAY A. D., Axford A. T. Letter: Pleural effusions after practolol. Lancet. 1976 Jan 10;1(7950):89–89. doi: 10.1016/s0140-6736(76)90180-x. [DOI] [PubMed] [Google Scholar]
Raftery E. B., Denman A. M. Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973 May 26;2(5864):452–455. doi: 10.1136/bmj.2.5864.452. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES